Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA DR. REDDYS LAB AUROBINDO PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 12.9 24.0 53.7% View Chart
P/BV x 1.1 3.8 29.0% View Chart
Dividend Yield % 1.9 0.7 282.4%  

Financials

 AUROBINDO PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
DR. REDDYS LAB
Mar-22
AUROBINDO PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0645,614 18.9%   
Low Rs5843,655 16.0%   
Sales per share (Unadj.) Rs400.31,294.6 30.9%  
Earnings per share (Unadj.) Rs45.7126.9 36.0%  
Cash flow per share (Unadj.) Rs64.9196.9 33.0%  
Dividends per share (Unadj.) Rs9.0030.00 30.0%  
Avg Dividend yield %1.10.6 168.7%  
Book value per share (Unadj.) Rs419.41,145.8 36.6%  
Shares outstanding (eoy) m585.94166.43 352.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.13.6 57.5%   
Avg P/E ratio x18.036.5 49.4%  
P/CF ratio (eoy) x12.723.5 53.9%  
Price / Book Value ratio x2.04.0 48.6%  
Dividend payout %19.723.6 83.3%   
Avg Mkt Cap Rs m482,799771,272 62.6%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50938,858 88.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555215,452 108.9%  
Other income Rs m3,2264,847 66.6%   
Total revenues Rs m237,781220,299 107.9%   
Gross profit Rs m42,56637,674 113.0%  
Depreciation Rs m11,26511,652 96.7%   
Interest Rs m486958 50.8%   
Profit before tax Rs m34,04029,911 113.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2568,789 82.6%   
Profit after tax Rs m26,78421,122 126.8%  
Gross profit margin %18.117.5 103.8%  
Effective tax rate %21.329.4 72.5%   
Net profit margin %11.49.8 116.5%  
BALANCE SHEET DATA
Current assets Rs m181,227177,880 101.9%   
Current liabilities Rs m81,56097,658 83.5%   
Net working cap to sales %42.537.2 114.1%  
Current ratio x2.21.8 122.0%  
Inventory Days Days2556 45.0%  
Debtors Days Days62113 55.2%  
Net fixed assets Rs m155,104106,819 145.2%   
Share capital Rs m586832 70.4%   
"Free" reserves Rs m245,174189,859 129.1%   
Net worth Rs m245,760190,691 128.9%   
Long term debt Rs m2,4925,746 43.4%   
Total assets Rs m336,331284,699 118.1%  
Interest coverage x71.032.2 220.3%   
Debt to equity ratio x00 33.7%  
Sales to assets ratio x0.70.8 92.2%   
Return on assets %8.17.8 104.5%  
Return on equity %10.911.1 98.4%  
Return on capital %13.915.7 88.5%  
Exports to sales %31.147.1 65.9%   
Imports to sales %11.918.8 63.6%   
Exports (fob) Rs m72,862101,544 71.8%   
Imports (cif) Rs m27,96540,401 69.2%   
Fx inflow Rs m77,245101,544 76.1%   
Fx outflow Rs m31,52440,401 78.0%   
Net fx Rs m45,72161,143 74.8%   
CASH FLOW
From Operations Rs m50,16528,108 178.5%  
From Investments Rs m-32,116-26,387 121.7%  
From Financial Activity Rs m-29,693-2,422 1,226.0%  
Net Cashflow Rs m-11,67432 -36,481.3%  

Share Holding

Indian Promoters % 48.8 26.7 182.6%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 51.0 74.5%  
FIIs % 21.4 26.3 81.5%  
ADR/GDR % 0.0 10.1 -  
Free float % 48.2 63.2 76.2%  
Shareholders   358,459 259,271 138.3%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    CIPLA    LUPIN    ZYDUS LIFESCIENCES    SANOFI INDIA    


More on Aurobindo Pharma vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Dr. Reddys Share Price Performance

Period Aurobindo Pharma Dr. Reddys S&P BSE HEALTHCARE
1-Day 0.70% -0.38% 0.23%
1-Month -10.43% -1.34% 0.36%
1-Year -28.70% -6.30% -6.87%
3-Year CAGR 1.27% 13.92% 20.16%
5-Year CAGR -7.94% 13.98% 11.07%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.